Leli Zeng

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Multidrug Resistant

Cerebrospinal Fluid

Tyrosine Kinase

Top Venues

Journal of oncology

Journal of translational internal medicine

Advanced materials (Deerfield Beach, Fla.)

Chemical science

This page only lists publications with an associated author ORCID identifier.

Publications

Xing-Duo Dong, Qisi Lu, Yi-Dong Li, Chao-Yun Cai, Qiu-Xu Teng, Zi-Ning Lei, Zeng-Hui Wei, Fan Yin, Leli Zeng, Zhe-Sheng Chen
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells. Journal of translational internal medicine 12 (3) (2024)
Xing-Duo Dong, Qisi Lu, Yi-Dong Li, Chao-Yun Cai, Qiu-Xu Teng, Zi-Ning Lei, Zeng-Hui Wei, Fan Yin, Leli Zeng, Zhe-Sheng Chen
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells. Journal of translational internal medicine 12 (3) (2024)
Yuzhi Xu, Si-Yang Liu, Leli Zeng, Hansu Ma, Yanfei Zhang, Huihui Yang, Yuchen Liu, Shuo Fang, Jing Zhao, Yunsheng Xu, Charles R Ashby, Yu-Long He, Zong Dai, Yihang Pan
An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy. Advanced materials (Deerfield Beach, Fla.) 34 (43) (2022)
Huan Li, Xinghan Jin, Shi-Wei Zhang, Bo Li, Leli Zeng, Yu-Long He, Changhua Zhang
APY0201 Represses Tumor Growth through Inhibiting Autophagy in Gastric Cancer Cells. Journal of oncology 2022 (2022)
Yuhong Liu, Yixiang Gan, NiJiati AiErken, Wei Chen, Shiwei Zhang, Jie Ouyang, Leli Zeng, Di Tang
Combining Organoid Models with Next-Generation Sequencing to Reveal Tumor Heterogeneity and Predict Therapeutic Response in Breast Cancer. Journal of oncology 2022 (2022)
Ruilin Guan, Yu Chen, Leli Zeng, Thomas W Rees, Chengzhi Jin, Juanjuan Huang, Zhe-Sheng Chen, Liangnian Ji, Hui Chao
Oncosis-inducing cyclometalated iridium(iii) complexes. Chemical science 9 (23) (2018)